Toshihiko Kuro

407 total citations
14 papers, 322 citations indexed

About

Toshihiko Kuro is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Toshihiko Kuro has authored 14 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Toshihiko Kuro's work include Nitric Oxide and Endothelin Effects (10 papers), Renin-Angiotensin System Studies (6 papers) and Hormonal Regulation and Hypertension (5 papers). Toshihiko Kuro is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Renin-Angiotensin System Studies (6 papers) and Hormonal Regulation and Hypertension (5 papers). Toshihiko Kuro collaborates with scholars based in Japan, United Kingdom and United States. Toshihiko Kuro's co-authors include Yasuo Matsumura, Masanori Takaoka, Terry J. Opgenorth, Yutaka Kobayashi, Norio Hashimoto, Mamoru Ohkita, Jerry L. Wessale, Fumiko Konishi, Cheryl E. Gariepy and Masashi Yanagisawa and has published in prestigious journals such as Circulation, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Toshihiko Kuro

14 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshihiko Kuro Japan 10 198 159 96 62 41 14 322
Lisa C. Contino United States 12 152 0.8× 148 0.9× 116 1.2× 39 0.6× 16 0.4× 16 351
Tamara Chernihovsky Israel 8 177 0.9× 122 0.8× 81 0.8× 31 0.5× 32 0.8× 12 359
Tuula Tikkanen Finland 12 157 0.8× 287 1.8× 86 0.9× 96 1.5× 24 0.6× 23 499
Janet L. Hobbs United States 8 155 0.8× 115 0.7× 108 1.1× 63 1.0× 15 0.4× 12 347
Arnar Rafnsson Sweden 9 169 0.9× 122 0.8× 104 1.1× 52 0.8× 20 0.5× 13 372
Glória F.A. Mota Brazil 12 90 0.5× 167 1.1× 109 1.1× 104 1.7× 23 0.6× 12 466
D KASS United States 6 83 0.4× 256 1.6× 136 1.4× 53 0.9× 26 0.6× 9 501
Shin-ichiro Mita Japan 8 108 0.5× 135 0.8× 130 1.4× 115 1.9× 28 0.7× 11 369
Patricia N. Banfor United States 12 105 0.5× 175 1.1× 141 1.5× 41 0.7× 47 1.1× 14 430
S. Cerci Italy 13 141 0.7× 139 0.9× 80 0.8× 124 2.0× 31 0.8× 30 433

Countries citing papers authored by Toshihiko Kuro

Since Specialization
Citations

This map shows the geographic impact of Toshihiko Kuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshihiko Kuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshihiko Kuro more than expected).

Fields of papers citing papers by Toshihiko Kuro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshihiko Kuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshihiko Kuro. The network helps show where Toshihiko Kuro may publish in the future.

Co-authorship network of co-authors of Toshihiko Kuro

This figure shows the co-authorship network connecting the top 25 collaborators of Toshihiko Kuro. A scholar is included among the top collaborators of Toshihiko Kuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshihiko Kuro. Toshihiko Kuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Yamashita, Junji, Makoto Itoh, Toshihiko Kuro, et al.. (2001). RETRACTION: Pre- or Post-Ischemic Treatment with a Novel Na+/Ca2+ Exchange Inhibitor, KB-R7943, Shows Renal Protective Effects in Rats with Ischemic Acute Renal Failure. Journal of Pharmacology and Experimental Therapeutics. 296(2). 412–419. 8 indexed citations
2.
Matsumura, Yasuo, et al.. (2000). Protective Effect of SM-19712, a Novel and Potent Endothelin Converting Enzyme Inhibitor, on Ischemic Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 84(1). 16–25. 25 indexed citations
3.
Kuro, Toshihiko, et al.. (2000). Effects of SA7060, a Novel Dual Inhibitor of Neutral Endopeptidase and Angiotensin-Converting Enzyme, on Deoxycorticosterone Acetate-Salt-Induced Hypertension in Rats.. Biological and Pharmaceutical Bulletin. 23(7). 820–825. 10 indexed citations
4.
Kuro, Toshihiko, Yutaka Kobayashi, Masanori Takaoka, et al.. (2000). Selective Antagonism of the ETA Receptor, but Not the ETB Receptor, Is Protective Against Ischemic Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 82(4). 307–316. 36 indexed citations
5.
Matsumura, Yasuo, Toshihiko Kuro, Yutaka Kobayashi, et al.. (2000). Increased Susceptibility to Deoxycorticosterone Acetate-Salt-Induced Hypertension in Endothelin-B-Receptor-Deficient Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S86–S89. 5 indexed citations
6.
Takaoka, Masanori, Toshihiko Kuro, & Yasuo Matsumura. (2000). Role of endothelin in the pathogenesis of acute renal failure. Drug News & Perspectives. 13(3). 141–141. 9 indexed citations
7.
Matsumura, Yasuo, Toshihiko Kuro, Fumiko Konishi, et al.. (2000). Enhanced blood pressure sensitivity to DOCA‐salt treatment in endothelin ETB receptor‐deficient rats. British Journal of Pharmacology. 129(6). 1060–1062. 23 indexed citations
8.
Matsumura, Yasuo, Toshihiko Kuro, Yutaka Kobayashi, et al.. (2000). Exaggerated Vascular and Renal Pathology in Endothelin-B Receptor–Deficient Rats With Deoxycorticosterone Acetate–Salt Hypertension. Circulation. 102(22). 2765–2773. 55 indexed citations
9.
Kuro, Toshihiko, Yutaka Kobayashi, Masanori Takaoka, & Yasuo Matsumura. (1999). Protective Effect of KB-R7943, a Novel Na+/Ca2+ Exchange Inhibitor, on Ischemic Acute Renal Failure in Rats.. The Japanese Journal of Pharmacology. 81(2). 247–251. 12 indexed citations
10.
Matsumura, Yasuo, Norio Hashimoto, Toshihiko Kuro, et al.. (1999). Different Contributions of Endothelin-A and Endothelin-B Receptors in the Pathogenesis of Deoxycorticosterone Acetate–Salt–Induced Hypertension in Rats. Hypertension. 33(2). 759–765. 98 indexed citations
11.
Takaoka, Masanori, et al.. (1999). Proteasome participates in the pathogenesis of ischemic acute renal failure in rats. European Journal of Pharmacology. 384(1). 43–46. 21 indexed citations
12.
Kuro, Toshihiko, Yutaka Kobayashi, Masanori Takaoka, & Yasuo Matsumura. (1999). Protective Effect of KB-R7943, a Novel Na+/Ca2+ Exchange Inhibitor, on Ischemic Acute Renal Failure in Rats. The Japanese Journal of Pharmacology. 81(2). 247–252. 4 indexed citations
13.
Hashimoto, Naoyuki, et al.. (1998). Endothelin ETB Receptor-Mediated Action on Systemic and Renal Hemodynamics and Urine Formation in Deoxycorticosterone Acetate-Salt-Induced Hypertensive Rats.. Biological and Pharmaceutical Bulletin. 21(8). 800–804. 12 indexed citations
14.
Hashimoto, Norio, et al.. (1998). Different Contributions of the Endothelin ETA Receptor to Hypertension Induced by Acute or Chronic Inhibition of Nitric Oxide Synthesis. Journal of Pharmacy and Pharmacology. 50(9). 1051–1058. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026